CoreLink Surpasses 5,000 Entasis SI Joint Fusion Implantations With Patented Stackable Guide Wires

What To Know

  • “CoreLink is proud to be a leader in the SI fusion market as a result of our strong product offering and vast training resources,”.
  • Lower back pain is one of the most common reasons for a physician visit and those experiencing pain attributable to the SI joint range from 15 to 30 percent3.

CoreLink also announced the company has been awarded patent number 11,052,229 by the United States Patent and Trademark Office (USPTO). The patent, titled, “Devices and methods for guidewire extension in spinal surgery,” expands the company’s intellectual property portfolio. These unique stackable guide wires are designed to give surgeons streamlined instruments and constant proximal control during every step of these lateral SI joint fusion procedures.

With the spine market expected to increase 5 percent this year1 and sacroiliac joint fusion growing up to 14.7 percent2, SI joint fusion continues to be an exciting new area of spine surgery. Lower back pain is one of the most common reasons for a physician visit and those experiencing pain attributable to the SI joint range from 15 to 30 percent3.

Entasis is designed for minimally invasive SI joint fusion procedures. The system provides an array of joint stabilizing compression screw options in three diameters and nine length options, enabling surgeons to precisely fit varying patient anatomies. The screws feature circumferential fenestrations that self-harvest bone graft while compressing the joint. Dual leads threads ease insertion and easy-out threaded removal tools are available, if needed. These innovative features and stackable guide wire have led to the Entasis system being recognized as a top 10 sacroiliac joint fusion system by SPINEMarketGroup. A full suite of resources to assist in surgeon training, patient education, and patient workup is also available.

“CoreLink is proud to be a leader in the SI fusion market as a result of our strong product offering and vast training resources,” said Jay Bartling, CEO, CoreLink. “Every step of our process, from design to manufacturing, keeps surgeon ease of use and patient outcomes top of mind. This is evident in our SI joint fusion systems with patented technology, unique compression screw design, and comprehensive offerings.”

CoreLink will be exhibiting at the North American Spine Society’s annual meeting in Boston, September 29 through October 2, booth #3221, where a full display of surgical systems will be featured, including Entasis.


References

1.

The Spine Market Group. (2021). What is the Spine Market First Estimate for 2021. Retrieved from http://thespinemarketgroup.com/which-is-the-spine-market-first-estimate-for-2021.

2.

360 Research Reports. (2020). Global MIS Sacroiliac Joint Fusion Sales Market Report 2020. Retrieved from https://www.360researchreports.com/global-mis-sacroiliac-joint-fusion-sales-market-16695557.

3.

Martin, C. T., Haase, L., Lender, P. A., & Polly, D. W. (2020). Minimally Invasive Sacroiliac Joint Fusion: The Current Evidence. International journal of spine surgery, 14(Suppl 1), 20–29. https://doi.org/10.14444/6072

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.
The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version